India, July 23 -- Edwards Lifesciences Corp. (EW) on Thursday reported a lower profit in the second quarter, as revenues increased 14%.
Net income declined to $241.9 million or $0.42 per share from $333.2 million or $0.56 per share last year, primarily reflecting a higher tax provision and impairment charges.
Adjusted earnings were $0.78 per share, compared with $0.67 per share a year earlier.
Second-quarter net sales increased 13.6% to $1.74 billion from $1.53 billion a year ago, while constant-currency sales grew 12.5%.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Transcatheter Aortic Valve Replacement (TAVR) sales rose 11.3% to $1.26 billion, and Transcatheter Mitral and Tricuspid Therapies (T...